SEC Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted to the U.S. Securities and Exchange Commission. The reporting entity is Lloyds Banking Group Plc, and the data reflects holdings as of the period ending December 31, 2014. This form discloses equity securities held by institutional investment managers, not the operating financial results of Lloyds Banking Group itself.
Key Financial Metrics and Holdings
The filing details a portfolio of U.S. equity securities and exchange-traded funds (ETFs). The table lists the issuer, title of class, CUSIP, value (in thousands of USD), and share/principal amount for each position. Voting authority is reported as "Sole" for all listed positions.
| Issuer | Value ($000s) | Shares/Principal |
|---|---|---|
| Pfizer Inc | 121,490 | 3,785 |
| E M C Corp Mass | 95,362 | 2,837 |
| Microsoft Corp | 73,698 | 3,424 |
| Johnson & Johnson | 34,819 | 3,641 |
| BorgWarner Inc | 36,734 | 2,017 |
| Qualcomm Inc | 30,002 | 2,230 |
| Wells Fargo & Co | 28,220 | 1,547 |
| JPMorgan Chase & Co | 28,080 | 1,757 |
| Verizon Communications Inc | 25,892 | 1,210 |
| Deere & Co | 25,851 | 2,286 |
Note: The table above lists select top holdings by value. The full filing contains 50 distinct positions including ETFs such as SPDR S&P 500 and iShares Trust.
Material Changes
The filing text provided is a static snapshot of holdings as of December 31, 2014. It does not contain comparative data from the prior quarter or year, nor does it explicitly state material changes in position size versus the previous reporting period.
Guidance, Outlook, and Risks
This document is a regulatory disclosure of asset ownership and does not contain management commentary, financial guidance, outlook, risk factors, or contingencies regarding Lloyds Banking Group's operations or the performance of the underlying securities.
Investor Verification Checklist
- Portfolio Composition: Verify the total aggregate value of the reported holdings to understand the scale of Lloyds' U.S. equity exposure.
- Concentration Risk: Assess the weight of top holdings (e.g., Pfizer, EMC, Microsoft) relative to the total portfolio.
- Discretion: Confirm that all listed positions are held with "Sole" voting discretion, indicating direct control by the manager.
- Missing Data: Note that revenue, profit, cash flow, and debt metrics for Lloyds Banking Group are not present in this specific filing type.